Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950133-09-001278
Filing Date
2009-04-29
Accepted
2009-04-28 19:43:56
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A w73766e10vkza.htm 10-K/A 1635536
2 EXHIBIT 23.1 w73766exv23w1.htm EX-23.1 3063
3 EXHIBIT 31.1 w73766exv31w1.htm EX-31.1 8858
4 EXHIBIT 31.2 w73766exv31w2.htm EX-31.2 8848
5 EXHIBIT 32.1 w73766exv32w1.htm EX-32.1 5594
6 EXHIBIT 32.2 w73766exv32w2.htm EX-32.2 5584
7 GRAPHIC w73766w7376601.gif GRAPHIC 9307
  Complete submission text file 0000950133-09-001278.txt   1681909
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34186 | Film No.: 09777130
SIC: 2834 Pharmaceutical Preparations